News
ImmunoGen CFO Christopher Missling leaves - MarketWatch
www.marketwatch.com
Updated Oil prices log highest settlement since July :03 P.M. ET
Christopher Missling, MS, PhD, MBA, is Now CEO of Anavex ...www.twst.com › news › christopher-missling-ms-phd-mb...
www.twst.com
Christopher Missling, MS, PhD, MBA, is Now CEO of Anavex Life Science, Developing Drugs for Alzheimers and Parkinsons. November
Anavex enrols first patient in Phase llb/lll trial of ANAVEX2-73
www.clinicaltrialsarena.com
Anavex president and CEO Christopher Missling said: “This is an important step toward achieving clinical data in regard to the treatment of ...
Relief from Rett? - News Articlewww.ddn-news.com › ...
www.drugdiscoverynews.com
... we decided to explore Anavex in Rett syndrome,” Christopher Missling, CEO of Anavex, tells DDNews. “Recent third-party publications also indicated a ...
sorted by relevance / date